Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001084442 | SCV000290060 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000434583 | SCV000510877 | benign | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000438106 | SCV000534464 | benign | not specified | 2016-12-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445397 | SCV000536988 | benign | Monogenic diabetes | 2018-10-12 | criteria provided, single submitter | research | ACMG criteria: BP1 (disease caused by truncating variants), BA1 (1.9% in gnomAD African), BS2 (6 homozygotes in gnomAD African), BP4 (7 predictors + REVEL 0.039)= benign |
Laboratory for Molecular Medicine, |
RCV000438106 | SCV000711801 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Lys3423Asn in exon 15 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 3.03% (40/1322) of African chromo somes by the 1000 Genomes Project (Phase 3; dbSNP rs34398445). |
Athena Diagnostics | RCV000434583 | SCV000840766 | likely benign | not provided | 2018-05-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000438106 | SCV000864097 | benign | not specified | 2017-02-06 | criteria provided, single submitter | clinical testing | Variant summary: The ALMS1 c.10269G>C (p.Lys3423Asn, alternative name c.10275G>C) variant involves the alteration of a non-conserved nucleotide and is predicted to be benign by 3/5 in silico tools. This variant was found in 211/120598 control chromosomes (including four homozygotes), predominantly observed in the African subpopulation at a frequency of 0.019804 (194/9796). This frequency is about 9 times the estimated maximal expected allele frequency of a pathogenic ALMS1 variant (0.0022361), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. It has not, to our knowledge, been reported in affected individuals in literature. One clinical diagnostic laboratory has classified this variant as benign. Taken together this variant is classified as benign variant. |
Clinical Genomics, |
RCV001084442 | SCV002605264 | likely benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs34398445 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002379015 | SCV002692094 | benign | Cardiovascular phenotype | 2018-12-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV000434583 | SCV001798187 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000438106 | SCV001923851 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000438106 | SCV001926808 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000434583 | SCV001965534 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001084442 | SCV002078968 | benign | Alstrom syndrome | 2019-12-05 | no assertion criteria provided | clinical testing |